 |
市場調查報告書
商品編碼
1629632
藥物成癮治療市場：按類型、按治療方法、按給藥途徑、按最終用戶、按地區Drug Addiction Treatment Market, By Types, By Treatment, By Route of Administration, By End User,By Geography |
||||||
估計2024年全球成癮治療市場規模為176.1億美元，預計2031年將達287.2億美元，2024年至2031年年複合成長率為7.2%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 176.1億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 預測2024-2031年年複合成長率： | 7.20% | 2031年價值預測 | 287.2億美元 |
近年來，隨著藥物濫用在已開發國家和新興國家變得越來越普遍，全球藥物成癮治療市場一直穩定發展。根據聯合國毒品犯罪防制署（UNODC）的資料，2020年 6月，全球約有 2.69億人至少吸過一次毒。非法藥物的容易取得，加上社會經濟的脆弱性，大大加劇了藥物成癮危機。作為回應，各國政府正加緊努力提供實證治療服務，幫助人們克服吸毒障礙。這大幅增加了全球成癮治療市場對各種藥物和心理成癮治療和治療方法的需求。
市場動態：
推動全球藥物成癮治療市場成長的主要因素包括社會接受藥物濫用障礙作為一種需要治療而不是定罪的醫療狀況、擴大治療設施，其中包括政府增加醫療保健支出和增加鴉片類止痛藥的使用，這加劇了鴉片類藥物危機。然而，缺乏戒毒後社會支持計劃、藥物濫用治療的恥辱以及缺乏接受過專門成癮治療培訓的醫療保健專業人員等因素給市場相關人員帶來了挑戰。從積極的一面來看，進行的具有更好安全性和有效性的新型療法的研究，以及數位技術在諮詢計畫中的整合，為相關人員提供了高成長機會。
本研究的主要特點
本報告對全球成癮治療市場進行了詳細分析，並提出了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、績效和策略等參數，對全球成癮治療市場的主要企業進行概況分析。
本研究涵蓋的主要企業包括 Indivior PLC、Pfizer Inc.、Johnson &Johnson、Alkermes、Mallinckrodt Pharmaceuticals、Teva Pharmaceutical Industries、GSK Plc.、AbbVie Inc.、Otsuka Pharmaceutical Co., Ltd.、Lundbeck A/S、Hikma Pharmaceuticals、Alkermes Plc.、Sandoz（a Novartis division）、AcelRx Pharmaceuticals、Nuvectra Corporation等
本報告的見解讓負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球藥物成癮治療市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球藥物成癮治療市場的各種策略矩陣來促進他們的決策。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章 市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要進展
- 監管場景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
- 產業動態
第4章 全球藥物成癮治療市場，依類型，2019-2031
- 鴉片類藥物成癮
- 苯二氮平類藥物成癮
- 巴比妥中毒
- 其他
第5章 全球成癮治療市場，依治療方法，2019-2031
- 治療
- 藥物治療
- 其他
第6章 全球藥物成癮治療市場，依給藥途徑，2019-2031
- 口服
- 胃腸外
- 其他
第7章 全球藥物成癮治療市場，依最終使用者分類，2019-2031年
- 醫院
- 專科診所
- 復健中心
- 其他
第8章 2019-2031年全球成癮治療市場（依地區）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章 競爭格局
- Indivior PLC
- Pfizer Inc.
- Johnson & Johnson
- Alkermes
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceutical Industries
- GSK Plc.
- AbbVie Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Lundbeck A/S
- Hikma Pharmaceuticals
- Alkermes Plc.
- Sandoz（a Novartis division）
- AcelRx Pharmaceuticals
- Nuvectra Corporation
第10章 分析師建議
- 命運之輪
- 分析師觀點
- Coherent Opportunity Map
第11章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
The global drug addiction treatment market is estimated to be valued at USD 17.61 Bn in 2024 and is expected to reach USD 28.72 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 17.61 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 7.20% | 2031 Value Projection: | US$ 28.72 Bn |
The global drug addiction treatment market has been witnessing steady growth in the recent past owing to the rising prevalence of drug abuse across both developed and developing nations worldwide. In June 2020, according to the United Nations Office on Drugs and Crime (UNODC), around 269 million people worldwide used drugs at least once in 2020. The easy availability of illicit substances coupled with socio-economic vulnerabilities has significantly contributed to the drug addiction crisis. In response, governments across countries have been ramping up efforts to provide evidence-based treatment services to help individuals overcome substance use disorders. This has majorly driven the demand for various pharmacological and psychological addiction treatment drugs and therapies in the global drug addiction treatment market.
Market Dynamics:
The key drivers propelling the global drug addiction treatment market growth include growing social acceptance of drug abuse disorders as a medical condition requiring treatment instead of criminalization, increasing healthcare spending by governments to expand treatment facilities, and rising number of opioid analgesic users contributing to the opioid crisis. However, factors such as lack of social support programs post-detoxification, stigma associated with substance abuse treatment, and scarcity of medical professionals with specialized addiction treatment training pose challenges to market players. On the positive side, ongoing research for novel treatment drugs with better safety and efficacy profiles as well as integration of digital technologies in counseling programs present high-growth opportunities for stakeholders.
Key Features of the Study:
This report provides an in-depth analysis of the global drug addiction treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global drug addiction treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Indivior PLC, Pfizer Inc., Johnson & Johnson, Alkermes, Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries, GSK Plc., AbbVie Inc., Otsuka Pharmaceutical Co., Ltd., Lundbeck A/S, Hikma Pharmaceuticals, Alkermes Plc., Sandoz (a Novartis division), AcelRx Pharmaceuticals, and Nuvectra Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global drug addiction treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug addiction treatment market
Market Segmentation
- By Types Insights (Revenue, USD Bn, 2019 - 2031)
- Opioid Addiction
- Benzodiazepine Addiction
- Barbiturate Addiction
- Others
- By Treatment Insights (Revenue, USD Bn, 2019 - 2031)
- Therapy
- Medication
- Others
- By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Others
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Specialty Clinics
- Rehabilitation Center
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Indivior PLC
- Pfizer Inc.
- Johnson & Johnson
- Alkermes
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceutical Industries
- GSK Plc.
- AbbVie Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Lundbeck A/S
- Hikma Pharmaceuticals
- Alkermes Plc.
- Sandoz (a Novartis division)
- AcelRx Pharmaceuticals
- Nuvectra Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Drug Addiction Treatment Market, By Types
- Global Drug Addiction Treatment Market, By Treatment
- Global Drug Addiction Treatment Market, By Route of Administration
- Global Drug Addiction Treatment Market, By End User
- Global Drug Addiction Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Drug Addiction Treatment Market, By Types, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Opioid Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Benzodiazepine Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Barbiturate Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Drug Addiction Treatment Market, By Treatment, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Drug Addiction Treatment Market, By Route of Administration, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Drug Addiction Treatment Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Rehabilitation Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Drug Addiction Treatment Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Indivior PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alkermes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceutical Industries
- GSK Plc.
- AbbVie Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Lundbeck A/S
- Hikma Pharmaceuticals
- Alkermes Plc.
- Sandoz (a Novartis division)
- AcelRx Pharmaceuticals
- Nuvectra Corporation
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
